Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2026)

Charles River Laboratories International (CRL) posted Non-Current Assets of $6.0 billion for Q2 2026, down 3.82% on a QoQ basis from $6.2 billion in Q1 2026, and down 1.44% year-over-year from $6.1 billion in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Non-Current Assets for 18 years, with the latest figure at $6.0 billion in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 1.44% year-over-year to $6.0 billion in Q2 2026; TTM through Jun 2026 was $23.9 billion, a 3.57% decrease from a year earlier, with the FY2025 full-year figure at $5.7 billion, down 7.13% from the prior year.
  • Non-Current Assets was $6.0 billion for Q2 2026 at Charles River Laboratories International, down from $6.2 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $6.6 billion in Q4 2023, with the low at $5.7 billion in Q4 2025.
  • Average Non-Current Assets over 5 years is $6.2 billion, with a median of $6.1 billion recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 30.92% in 2022, then slipped 8.1% in 2025.
  • Over 5 years, Non-Current Assets stood at $6.2 billion in 2022, then grew by 6.86% to $6.6 billion in 2023, then fell by 7.0% to $6.1 billion in 2024, then slipped by 7.13% to $5.7 billion in 2025, then advanced by 5.53% to $6.0 billion in 2026.
  • The last three Non-Current Assets figures came in at $6.0 billion (Q2 2026), $6.2 billion (Q1 2026), and $5.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 23.66 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.01 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 12.65 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 6.00 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 1.79 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 982.30 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 657.51 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 14.00 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 3.66 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 621,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 6.00 Bn
Mar 28, 2026 6.24 Bn
Dec 27, 2025 5.69 Bn
Sep 27, 2025 5.98 Bn
Jun 28, 2025 6.09 Bn
Mar 29, 2025 6.08 Bn
Dec 28, 2024 6.13 Bn
Sep 28, 2024 6.51 Bn
Jun 29, 2024 6.45 Bn
Mar 30, 2024 6.48 Bn
Dec 30, 2023 6.59 Bn
Sep 30, 2023 6.16 Bn
Jul 1, 2023 6.27 Bn
Apr 1, 2023 6.25 Bn
Dec 31, 2022 6.16 Bn
Sep 24, 2022 5.97 Bn
Jun 25, 2022 6.14 Bn
Mar 26, 2022 5.74 Bn
Dec 25, 2021 5.75 Bn
Sep 25, 2021 5.68 Bn